TPIV - TapImmune, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue---
Cost of Revenue---
Gross Profit---
Operating Expenses
Research Development5,250.9853,800.0351,711.177
Selling General and Administrative6,412.1214,692.2344,447.781
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-11,663.106-8,492.269-6,158.958
Income from Continuing Operations
Total Other Income/Expenses Net680.9296,036.888-27,896.507
Earnings Before Interest and Taxes-10,982.177-2,455.381-34,055.465
Interest Expense--10.925
Income Before Tax-10,982.177-2,455.381-34,066.39
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-10,982.177-2,455.381-34,066.39
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-10,982.177-2,455.381-34,066.39
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-10,982.177-2,455.381-34,066.39